Skip to main content

Read an important notice regarding the data security incident McKesson reported on August 28, 2026. Read more.

Clinical Trials

BRCC Research Institute 2026

< All Clinical Trials

Epcoritamab + Rituximab and Lenalidomide vs. Chemoimmunotherapy in Previously Untreated Follicular Lymphoma

Disease Type: Lymphoma

A Phase 3, Multicenter, Randomized, Open-Label Trial to Evaluate the Safety and Efficacy of Epcoritamab + Rituximab and Lenalidomide (R2) compared to Chemoimmunotherapy in Previously Untreated Follicular Lymphoma

Locations

Roanoke

View on ClinicalTrials.gov